COVID-19 in the pregnant or postpartum MS patient: Symptoms and outcomes

Amber Salter; Anne H. Cross; Gary R. Cutter; Robert J. Fox; David K.B. Li; Bruce Bebo; June Halper; Pamela Kanellis; Kottil Rammohan; Scott D. Newsome

doi:10.1016/j.msard.2022.104028

COVID-19 in the pregnant or postpartum MS patient: Symptoms and outcomes

Amber Salter, Anne H. Cross, Gary R. Cutter, Robert J. Fox, David K.B. Li, Bruce Bebo, June Halper, Pamela Kanellis, Kottil Rammohan, Scott D. Newsome

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Abstract

Women with multiple sclerosis (MS) are often of childbearing age. Thirty-six women with MS who were pregnant (n = 27) or within 6 weeks postpartum (n = 9) were reported in the North American COViMS registry and their COVID-19 outcomes were described. One pregnant and one postpartum woman were hospitalized. No deaths occurred. To compare COVID-19 clinical outcomes in pregnant and postpartum females with females who were not pregnant or postpartum, a 1:2 propensity score match was performed. While not powered to detect small differences, it was reassuring that no increased risks for those with MS who were pregnant/postpartum were revealed.

Original language	English (US)
Article number	104028
Journal	Multiple Sclerosis and Related Disorders
Volume	65
DOIs	https://doi.org/10.1016/j.msard.2022.104028
State	Published - Sep 2022

Keywords

COVID-19
Multiple sclerosis
Postpartum
Pregnancy
SARS-CoV-2

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.1016/j.msard.2022.104028

Cite this

@article{89ee63b5c6a24f60bd7c495996bb9aa4,

title = "COVID-19 in the pregnant or postpartum MS patient: Symptoms and outcomes",

abstract = "Women with multiple sclerosis (MS) are often of childbearing age. Thirty-six women with MS who were pregnant (n = 27) or within 6 weeks postpartum (n = 9) were reported in the North American COViMS registry and their COVID-19 outcomes were described. One pregnant and one postpartum woman were hospitalized. No deaths occurred. To compare COVID-19 clinical outcomes in pregnant and postpartum females with females who were not pregnant or postpartum, a 1:2 propensity score match was performed. While not powered to detect small differences, it was reassuring that no increased risks for those with MS who were pregnant/postpartum were revealed.",

keywords = "COVID-19, Multiple sclerosis, Postpartum, Pregnancy, SARS-CoV-2",

author = "Amber Salter and Cross, {Anne H.} and Cutter, {Gary R.} and Fox, {Robert J.} and Li, {David K.B.} and Bruce Bebo and June Halper and Pamela Kanellis and Kottil Rammohan and Newsome, {Scott D.}",

note = "Publisher Copyright: {\textcopyright} 2022 Elsevier B.V.",

year = "2022",

month = sep,

doi = "10.1016/j.msard.2022.104028",

language = "English (US)",

volume = "65",

journal = "Multiple Sclerosis and Related Disorders",

issn = "2211-0348",

publisher = "Elsevier",

}

TY - JOUR

T1 - COVID-19 in the pregnant or postpartum MS patient

T2 - Symptoms and outcomes

AU - Salter, Amber

AU - Cross, Anne H.

AU - Cutter, Gary R.

AU - Fox, Robert J.

AU - Li, David K.B.

AU - Bebo, Bruce

AU - Halper, June

AU - Kanellis, Pamela

AU - Rammohan, Kottil

AU - Newsome, Scott D.

PY - 2022/9

Y1 - 2022/9

N2 - Women with multiple sclerosis (MS) are often of childbearing age. Thirty-six women with MS who were pregnant (n = 27) or within 6 weeks postpartum (n = 9) were reported in the North American COViMS registry and their COVID-19 outcomes were described. One pregnant and one postpartum woman were hospitalized. No deaths occurred. To compare COVID-19 clinical outcomes in pregnant and postpartum females with females who were not pregnant or postpartum, a 1:2 propensity score match was performed. While not powered to detect small differences, it was reassuring that no increased risks for those with MS who were pregnant/postpartum were revealed.

AB - Women with multiple sclerosis (MS) are often of childbearing age. Thirty-six women with MS who were pregnant (n = 27) or within 6 weeks postpartum (n = 9) were reported in the North American COViMS registry and their COVID-19 outcomes were described. One pregnant and one postpartum woman were hospitalized. No deaths occurred. To compare COVID-19 clinical outcomes in pregnant and postpartum females with females who were not pregnant or postpartum, a 1:2 propensity score match was performed. While not powered to detect small differences, it was reassuring that no increased risks for those with MS who were pregnant/postpartum were revealed.

KW - COVID-19

KW - Multiple sclerosis

KW - Postpartum

KW - Pregnancy

KW - SARS-CoV-2

UR - http://www.scopus.com/inward/record.url?scp=85134181168&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85134181168&partnerID=8YFLogxK

U2 - 10.1016/j.msard.2022.104028

DO - 10.1016/j.msard.2022.104028

M3 - Letter

C2 - 35839562

AN - SCOPUS:85134181168

SN - 2211-0348

VL - 65

JO - Multiple Sclerosis and Related Disorders

JF - Multiple Sclerosis and Related Disorders

M1 - 104028

ER -

COVID-19 in the pregnant or postpartum MS patient: Symptoms and outcomes

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this